CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
Neuromuscular blockade with rocuronium and reversal with sugammadexother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00895778
NCT00895778N/ACompleted
CompareCT.gov

Neuromuscular Blockade Improves Surgical Conditions

Technical University of Munich·interventional·Posted May 8, 2009·Updated Mar 19, 2013

In Brief

A clinical study evaluating Neuromuscular blockade with rocuronium and reversal with sugammadex for Neuromuscular Blockade. Completed, enrolled 57 participants across 1 site.

Detailed Summary

This study is designed to test the clinical hypothesis that a neuromuscular block improves surgical conditions, operation time, and post-operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 8, 2009
Enrollment StartMar 1, 2009
Primary CompletionDec 1, 2010
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.2 years ago

Interventions

Neuromuscular blockade with rocuronium and reversal with sugammadexother